Alnylam Pharmaceuticals, Inc.
2023 Q4 - 2025 Q4 (9 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 8,563 | 0.1% | 21,535 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 17,309 | 0.3% | 37,958 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 10,279 | 0.1% | 31,521 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 6,285 | 0.1% | 23,277 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,670 | 0.1% | 7,099 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 1,941 | 0.0% | 7,059 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 677 | 0.0% | 2,785 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 297 | 0.0% | 1,985 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 552 | 0.0% | 2,885 | 12/31/2023 |